Aethel Therapeutics' Guidelines for Developing Safe Therapeutics
Our Design goals:
1 Constrain chasing maximal efficacy (side effects may be plentiful)
2 Subtype or Circuit Selectivity (Targeting beneficial receptors while minimizing activation of negatives)
3 Allosteric Modulation as an Alternative to Orthosteric Activation
4 Aethel evaluates evidence from all sides to ensure a most objective result
5 Control Pharmacokinetics as aggressively as the pharmacology
6 Build abuse-liability assessments into the program at an early stage
The Science
PAM Mechanism
Precision targeting
Natural signaling
Low off-target risk
Optimal efficacy
Positive Allosteric Modulators enhance the body's intrinsic response to pain by binding to specific sites, ensuring highly targeted therapeutic effects.
Safety Advantage
Non-addictive
No respiratory lag
Reduced toxicity
High patient safety
Unlike opioids, PAM molecules offer a transformative safety profile, dramatically reducing the risk of respiratory depression and chemical dependency for chronic patients.
Long-term
Sustained relief
Proven safety
Better outcomes
Innovative pathways
Clinical data demonstrates that PAMs maintain efficacy over time without the diminishing returns or tolerance issues common in traditional analgesic treatments.